<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-01035R2</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0000827</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biophysics/Cell Signaling and Trafficking Structures</subject><subject>Physiology/Cardiovascular Physiology and Circulation</subject><subject>Physiology/Cell Signaling</subject><subject>Physiology/Sensory Systems</subject><subject>Cardiovascular Disorders/Coronary Artery Disease</subject><subject>Cardiovascular Disorders/Hemodynamics</subject><subject>Cardiovascular Disorders/Hypertension</subject><subject>Cardiovascular Disorders/Vascular Biology</subject></subj-group></article-categories><title-group><article-title>Arterial Response to Shear Stress Critically Depends on Endothelial TRPV4 Expression</article-title><alt-title alt-title-type="running-head">TRPV4 and Endothelial Function</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Hartmannsgruber</surname><given-names>Veronika</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Heyken</surname><given-names>Willm-Thomas</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kacik</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kaistha</surname><given-names>Anuradha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Grgic</surname><given-names>Ivica</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Harteneck</surname><given-names>Christian</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liedtke</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hoyer</surname><given-names>Joachim</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>K&#x000f6;hler</surname><given-names>Ralf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="n101"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Internal Medicine-Nephrology, Philipps-University, Marburg, Germany</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Institut f&#x000fc;r Pharmakologie, Charit&#x000e9; Campus Benjamin Franklin, Berlin, Germany</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Center for Translational Neuroscience, Duke University, Durham, North Carolina, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Mansvelder</surname><given-names>Huibert</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Vrije University Amsterdam, The Netherlands</aff><author-notes><corresp id="n101">&#x0002a; To whom correspondence should be addressed. E-mail: <email>rkoehler@med.uni-marburg.de</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: RK. Performed the experiments: CH WL RK VH WH IG AR MK AK. Analyzed the data: CH WL RK VH WH IG AR JH MK AK. Contributed reagents/materials/analysis tools: CH WL RK JH. Wrote the paper: CH WL RK.</p></fn></author-notes><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>5</day><month>9</month><year>2007</year></pub-date><volume>2</volume><issue>9</issue><elocation-id>e827</elocation-id><history><date date-type="received"><day>5</day><month>4</month><year>2007</year></date><date date-type="accepted"><day>9</day><month>8</month><year>2007</year></date></history><copyright-statement>Hartmannsgruber et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2007</copyright-year><abstract><sec><title>Background</title><p>In blood vessels, the endothelium is a crucial signal transduction interface in control of vascular tone and blood pressure to ensure energy and oxygen supply according to the organs' needs. In response to vasoactive factors and to shear stress elicited by blood flow, the endothelium secretes vasodilating or vasocontracting autacoids, which adjust the contractile state of the smooth muscle. In endothelial sensing of shear stress, the osmo- and mechanosensitive Ca<sup>2&#x0002b;</sup>-permeable TRPV4 channel has been proposed to be candidate mechanosensor. Using TRPV4<sup>&#x02212;/&#x02212;</sup> mice, we now investigated whether the absence of endothelial TRPV4 alters shear-stress-induced arterial vasodilation.</p></sec><sec><title>Methodology/Principal Findings</title><p>In TRPV4<sup>&#x02212;/&#x02212;</sup> mice, loss of the TRPV4 protein was confirmed by Western blot, immunohistochemistry and by <italic>in situ</italic>-patch&#x02013;clamp techniques in carotid artery endothelial cells (CAEC). Endothelium-dependent vasodilation was determined by pressure myography in carotid arteries (CA) from TRPV4<sup>&#x02212;/&#x02212;</sup> mice and wild-type littermates (WT). In WT CAEC, TRPV4 currents could be elicited by TRPV4 activators 4&#x003b1;-phorbol-12,13-didecanoate (4&#x003b1;PDD), arachidonic acid (AA), and by hypotonic cell swelling (HTS). In striking contrast, in TRPV4<sup>&#x02212;/&#x02212;</sup> mice, 4&#x003b1;PDD did not produce currents and currents elicited by AA and HTS were significantly reduced. 4&#x003b1;PDD caused a robust and endothelium-dependent vasodilation in WT mice, again conspicuously absent in TRPV4<sup>&#x02212;/&#x02212;</sup> mice. Shear stress-induced vasodilation could readily be evoked in WT, but was completely eliminated in TRPV4<sup>&#x02212;/&#x02212;</sup> mice. In addition, flow/reperfusion-induced vasodilation was significantly reduced in TRPV4<sup>&#x02212;/&#x02212;</sup> vs. WT mice. Vasodilation in response to acetylcholine, vasoconstriction in response to phenylephrine, and passive mechanical compliance did not differ between genotypes, greatly underscoring the specificity of the above <italic>trpv4</italic>-dependent phenotype for physiologically relevant shear stress.</p></sec><sec><title>Conclusions/Significance</title><p>Genetically encoded loss-of-function of <italic>trpv4</italic> results in a loss of shear stress-induced vasodilation, a response pattern critically dependent on endothelial TRPV4 expression. Thus, Ca<sup>2&#x0002b;</sup>-influx through endothelial TRPV4 channels is a molecular mechanism contributing significantly to endothelial mechanotransduction.</p></sec></abstract><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>In vascular physiology, Ca<sup>2&#x0002b;</sup>-influx in response to mechanical or agonist stimulation plays a pivotal role in a variety of endothelial functions, in particular in the Ca<sup>2&#x0002b;</sup>-dependent synthesis of endothelium-derived vasodilating factors such as diffusible nitric oxide <xref ref-type="bibr" rid="pone.0000827-Furchgott1">&#x0005b;1&#x0005d;</xref> and prostacyclin <xref ref-type="bibr" rid="pone.0000827-Moncada1">&#x0005b;2&#x0005d;</xref>, as well as the endothelium-derived hyperpolarizing factor (EDHF). EDHF-mediated vasodilation represents a considerable proportion of total vasodilation, which is resistant to inhibitors of nitric oxide- and prostacyclin synthesis, and is caused by endothelium-dependent hyperpolarization of smooth muscle and subsequent closure of voltage-gated Ca<sup>2&#x0002b;</sup>-channels leading to relaxation <xref ref-type="bibr" rid="pone.0000827-Nilius1">&#x0005b;3&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000827-Khler1">&#x0005b;5&#x0005d;</xref>. Ca<sup>2&#x0002b;</sup>-permeable cation channels of the transient receptor gene super-family (TRP) <xref ref-type="bibr" rid="pone.0000827-Clapham1">&#x0005b;6&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000827-Liedtke1">&#x0005b;13&#x0005d;</xref> have been proposed to function as Ca<sup>2&#x0002b;</sup> entry pathway in response to stimulation of G-protein-coupled receptors, as well as to mechanical stimulation by increased flow or shear stress <xref ref-type="bibr" rid="pone.0000827-Nilius2">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-ONeil1">&#x0005b;14&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000827-Liedtke2">&#x0005b;16&#x0005d;</xref>. Recent studies have provided pharmacological and molecular biological evidence that Ca<sup>2&#x0002b;</sup>-entry mediated by the endothelial TRP vanilloid type 4 channel (TRPV4) is involved in the synthesis of nitric oxide <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref> and in EDHF signaling <xref ref-type="bibr" rid="pone.0000827-Vriens1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000827-Marrelli1">&#x0005b;20&#x0005d;</xref>. TRPV4 channels <xref ref-type="bibr" rid="pone.0000827-Liedtke2">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Watanabe2">&#x0005b;21&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000827-Liedtke4">&#x0005b;26&#x0005d;</xref> can be polymodally activated by osmotic stress <xref ref-type="bibr" rid="pone.0000827-Watanabe2">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Strotmann1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Liedtke4">&#x0005b;26&#x0005d;</xref>, shear stress <xref ref-type="bibr" rid="pone.0000827-Liedtke2">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Gao1">&#x0005b;27&#x0005d;</xref>, moderate warmth (&#x0003e;27&#x000b0;C) <xref ref-type="bibr" rid="pone.0000827-Gler1">&#x0005b;28&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Watanabe3">&#x0005b;29&#x0005d;</xref>, arachidonic acid (AA) and its metabolite 5,6 epoxyeicosatrienoic acid (5,6 EET) <xref ref-type="bibr" rid="pone.0000827-Vriens1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Watanabe1">&#x0005b;19&#x0005d;</xref>, possibly by low pH <xref ref-type="bibr" rid="pone.0000827-Suzuki1">&#x0005b;30&#x0005d;</xref>, and pharmacologically by the non-PKC-activating phorbol ester, 4&#x003b1;-phorbol-12,13-didecanoate (4&#x003b1;PDD) <xref ref-type="bibr" rid="pone.0000827-Watanabe2">&#x0005b;21&#x0005d;</xref>. <italic>trpv4</italic> gene-targeted mice exhibit a subtle phenotype with deficits in the regulation of systemic tonicity by the central nervous system <xref ref-type="bibr" rid="pone.0000827-Liedtke3">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Liedtke5">&#x0005b;31&#x0005d;</xref>, altered transduction of noxious stimuli <xref ref-type="bibr" rid="pone.0000827-Liedtke3">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-AlessandriHaber1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Todaka1">&#x0005b;32&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000827-Grant1">&#x0005b;34&#x0005d;</xref>, and, amongst other phenotypes, defects in the lung alveolar barrier <xref ref-type="bibr" rid="pone.0000827-Alvarez1">&#x0005b;35&#x0005d;</xref> and in renal tubular K<sup>&#x0002b;</sup> secretion <xref ref-type="bibr" rid="pone.0000827-Taniguchi1">&#x0005b;36&#x0005d;</xref>.</p><p>We recently presented pharmacological evidence that endothelial TRPV4 may function in signal transduction in response to flow or shear stress <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref>. To further analyze TRPV4-mediated mechanisms in vascular endothelial function in a more definitive manner, we now tested shear stress and agonist-induced endothelium-dependent vasodilation in mice lacking the TRPV4 channel <xref ref-type="bibr" rid="pone.0000827-Liedtke3">&#x0005b;24&#x0005d;</xref>. As a result, we demonstrate in carotid arteries from TRPV4<sup>-/&#x02212;</sup> mice that (1) these vessels do not relax in response to 4&#x003b1;PDD, (2) shear stress-induced vasodilation is fully eliminated, and (3) flow-induced vasodilation is greatly attenuated, whereas agonist-induced vasodilation and constriction were intact. In summary, our data provide support for an essential role of TRPV4 in the response of arterial endothelia to shear stress.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>TRPV4<sup>&#x02212;/&#x02212;</sup> mice, carotid artery preparation, and carotid artery endothelial cells</title><p>Genotyping of TRPV4<sup>&#x02212;/&#x02212;</sup> mice <xref ref-type="bibr" rid="pone.0000827-Liedtke3">&#x0005b;24&#x0005d;</xref> was performed by polymerase chain reaction (PCR) of genomic tail DNA. Primers: Forward primer (binds to Exon 11): CGCTTCCTGCTTGTGTACCT; Reverse primer 1 (binds to Exon 13): <named-content content-type="gene">GGAGTGCCATCTGAGCTCTT</named-content>. Product size: WT, &#x0223c;3.6 kb; TRPV4<sup>&#x02212;/&#x02212;</sup>, &#x0223c;2.0 kb; Reverse primer 2 (binds to Exon 12): <named-content content-type="gene">CGATGGTGAGCTTGAAGAGG</named-content>. Product size: WT, &#x0223c;1.7 kb; TRPV4<sup>&#x02212;/&#x02212;</sup>, no signal.</p><p>To confirm the lack of the TRPV4 protein, we performed immunohistochemistry in carotid arteries (CA) of TRPV4<sup>&#x02212;/&#x02212;</sup> and wild-type mice. Animals were fixed by transcardiac perfusion with 10 &#x00025; neutral-buffered formalin, post-fixed by overnight immersion in the same fixative, and infused with sucrose. Frozen blocks were sectioned at 12 &#x000b5;m, mounted and immunolabeled using a TRPV4 C-term specific antibody raised in rabbits against a synthetic peptide encompassing positions 855 to 873 of mouse TRPV4 (CDGHQQGYPRKWRTDDAPL), as described previously <xref ref-type="bibr" rid="pone.0000827-Liedtke3">&#x0005b;24&#x0005d;</xref>. Secondary detection was accomplished using a goat anti-rabbit antibody, conjugated to Alexafluor 594 (Invitrogen-Molecular Probes, Carlsbad, CA, USA). Labeled sections of CA were imaged and photographed using an Olympus BX60 upright microscope, RFP filter set, a Roper Coolsnap high-res digital camera, using ISEE image processing software (ISEE, Raleigh, NC, USA).</p><p>Western blotting: Experiments were performed using an affinity-purified, polyclonal anti-TRPV4 antibody. The antibody was directed against the synthetic peptide from position 853 to 868 (CDGHQQGYAPKWRTDD) of TRPV4 <xref ref-type="bibr" rid="pone.0000827-Reiter1">&#x0005b;37&#x0005d;</xref>. In brief, frozen kidneys from each genotype were ground under nitrogen and subsequently homogenized in 50 mM Tris, 1 mM EDTA, 2 mM DTT, 0.2 &#x000b5;M benzamidine, 50 mM leupeptin, 0.5 mM PMSF, 0.1 mg/ml trpysin inhibitor pH 8.0 (homogenization buffer). Debris and nuclear material were removed by centrifugation at 1000&#x000d7;g for 2 min. Membrane proteins were collected by centrifugation at 20,000&#x000d7;g for 45 min, resuspended in homogenization buffer, quantified using the Bio-Rad Protein Assay. 20 &#x000b5;g of membrane proteins were separated by sodium dodecylsulfate&#x02013;polyacrylamide gel electrophoresis (SDS-PAGE), and electrophoretically transferred to nitrocellulose membranes (Trans-Blot, all from Bio-Rad, Munich, Germany). TRPV4 protein was visualized by an anti-TRPV4 antibody <xref ref-type="bibr" rid="pone.0000827-Reiter1">&#x0005b;37&#x0005d;</xref>, a peroxidase-conjugated anti-rabbit antiserum (GE Healthcare europe, Freiburg, Germany) and ECL advance Western blot detection system (GE Healthcare). Equal loading of proteins was validated by incubation of the Western blot with an anti-tubulin antibody (Labvision, Fremont, CA).</p></sec><sec id="s2b"><title>Electrophysiology</title><p>For patch clamp experiments in carotid artery endothelial cells (CAEC) <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref>, freshly isolated segments of the right and left carotid artery (CA) from female and male TRPV4<sup>&#x02212;/&#x02212;</sup> mice and WT littermates were mounted on a glass capillary with the endothelium facing the bath solution and incubated with 0.05&#x00025; trypsin and 0.02&#x00025; ethylenediaminetetraacetic acid (EDTA) in phosphate buffered saline (PBS) without Ca<sup>2&#x0002b;</sup>/Mg<sup>2&#x0002b;</sup> for up to 10 min, and then washed. For whole-cell patch-clamp experiments, the patch pipette was approached to the luminal surface and a single CAEC was fixed at the tip of the patch pipette by applying a negative pressure (&#x02212;5 mmHg) to the pipette. After formation of a giga-&#x003a9; seal, the cell was carefully detached from the luminal face of the vessel. To achieve electrical access to the cytosol, a negative pressure (&#x0223c;&#x02212;50 mmHg) was applied to the pipette leading to rupture of the membrane patch within the tip. Whole-cell membrane currents in CAEC were recorded with an EPC-9 (HEKA) patch-clamp amplifier using voltage ramps (duration: 1000 ms) from &#x02212;100 to &#x0002b;100 mV as described previously <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref>. Initial ohmic leak currents up to 500 pS were subtracted by using the leak correction mode of the EPC9. Cells exhibiting larger leak currents or becoming unstable over time were not further considered. Patch pipettes had tip resistances of 2&#x02013;4 M&#x003a9; in symmetrical KCl solutions. If not otherwise stated, the standard pipette solution was composed of (in mmol/L): 20 CsCl, 100 cesium methane sulfonate, 1 MgCl<sub>2</sub>, 4 Na<sub>2</sub>ATP, 10 EGTA, 0.9 CaCl<sub>2</sub>, 10 HEPES, pH adjusted to 7.2 with CsOH; calculated free &#x0005b;Ca<sup>2&#x0002b;</sup>&#x0005d; was 0.04 &#x000b5;mol/L. The standard NaCl bath solution contained (mmol/L): 137 NaCl, 4.5 Na<sub>2</sub>HPO<sub>4</sub>, 3 KCl, 1.5 KH<sub>2</sub>PO<sub>4</sub>, 0.4 MgCl<sub>2</sub>, 10 glucose, and 1 CaCl<sub>2</sub> (pH 7.4). In experiments employing hypotonic stress, isotonic and hypotonic bath solutions consisted of (mmol/L): 90 NaCl, 1 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>,10 glucose, 10 HEPES, pH 7.4. The isotonic solution contained additionally 95 mmol/L mannitol. All experiments were performed at RT. Data analysis was performed as described previously <xref ref-type="bibr" rid="pone.0000827-Khler3">&#x0005b;38&#x0005d;</xref>.</p></sec><sec id="s2c"><title>Pressure myography</title><p>Pressure myography in CA was performed as described previously <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref>. Bath and perfusion solutions contained (in mmol/L): 145 NaCl, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 4.7 KCl, 1.2 MgSO<sub>4</sub>, 2 CaCl<sub>2</sub>, 5 glucose, 2 pyruvate, and 3 MOPS buffer (pH 7.4 at 37&#x000b0;C). CA were mounted on glass capillaries, pressurized to 80 mmHg and were stretched to their <italic>in vivo</italic> length. Initially, CA were continuously perfused at a flow rate of 30 &#x000b5;l/min elicited by a pressure gradient of 1 mmHg between inflow and outflow glass capillaries of equal dimensions. After an equilibration period of 30 min, CAs were pre-constricted with 1 &#x000b5;mol/L phenylephrine (PE) in the bath solution, if not stated otherwise. After development of stable tone, intravascular flow was re-established from almost static conditions (&#x0223c;30 &#x000b5;l/min) to physiologically relevant levels (600 &#x000b5;l/min) by increasing the pressure gradient between inflow and outflow capillaries to 20 mmHg. The shear stress increased from &#x0223c;0.1 to 3 dyne/cm<sup>2</sup>. The mean intraluminal pressure remains constant at 80 mmHg under these conditions. To measure sole shear stress-mediated vasodilation (without increasing flow rate), the viscosity of the perfusion medium was increased from 0.7 to 2.9 mPa&#x0002a;s by adding 5&#x00025; dextran which enhanced shear stress in CA from &#x0223c;3 to 7 dyne/cm<sup>2</sup>. Shear stress was mathematically estimated according to the Hagen-Poiseuille law: &#x003c4;&#x0200a;&#x0003d;&#x0200a;4&#x003b7;Q/&#x003c0;r<sup>3</sup>; &#x003c4;&#x0200a;&#x0003d;&#x0200a;shear stress; &#x003b7;&#x0200a;&#x0003d;&#x0200a;viscosity; Q&#x0200a;&#x0003d;&#x0200a;flow, and r&#x0200a;&#x0003d;&#x0200a;radius. In other sets of experiments, CAs were perfused with 4&#x003b1;PDD (1 &#x000b5;mol/L), or acetylcholine (ACh, 1 nmol/L&#x02013;10 &#x000b5;mol/L) in the presence and absence of the NO-synthase-inhibitor N<sup>G</sup>-nitro-L-arginine (L-NNA, 300 &#x000b5;mol/L) and the cyclooxygenase inhibitor indomethacin (INDO, 10 &#x000b5;mol/L). To study the dependence of 4&#x003b1;PPD-, shear stress-, as well as flow/reperfusion-induced vasodilation on endothelial intracellular Ca<sup>2&#x0002b;</sup>-signaling, the endothelium was preloaded with the Ca<sup>2&#x0002b;</sup>-chelator 1,2-bis-(<italic>o</italic>-aminophenoxy)ethane-<italic>N</italic>,<italic>N</italic>,<italic>N&#x02032;</italic>,<italic>N&#x02032;</italic>-tetraacetic acid tetra-(acetoxy-methyl) ester (BAPTA-AM, 10 &#x000b5;mol/L) in the perfusion solution for 10 min, prior to stimulation. In another subset of experiments, the endothelium was pre-incubated with the PLA<sub>2</sub> inhibitor 1,1,1-trifluoromethyl-6,9,12,15-heieicosatetraen-2-one (AACOCF<sub>3</sub>, 3 &#x000b5;mol/L) for 10 min. Diameter changes were expressed as a percentage of the maximal dilatation induced by 10 &#x000b5;mol/L sodium nitroprusside (SNP). Maximal constriction was elicited by 60 mmol/L K<sup>&#x0002b;</sup>. Elasticity of CA was tested by increasing the intraluminal pressure in 20 mmHg steps to up to 140 mmHg in the presence of the NO-donor SNP. Chemicals were obtained from Sigma-Aldrich (M&#x000fc;nchen, Germany).</p></sec><sec id="s2d"><title>Statistical analysis</title><p>Data are given as mean&#x000b1;SEM. The unpaired Students <italic>t</italic>-Test was used to assess differences between groups. <italic>P</italic>-values of &#x0003c;0.05 were considered significant.</p></sec></sec><sec id="s3"><title>Results and Discussion</title><sec id="s3a"><title>Loss of cationic currents in response to 4&#x003b1;PDD, arachidonic acid and hypotonicity in carotid artery endothelial cells from TRPV4<sup>&#x02212;/&#x02212;</sup> mice</title><p>Expression of the TRPV4 protein was evident in the carotid endothelium and in kidney extracts of WT but not of TRPV4<sup>&#x02212;/&#x02212;</sup> mice as determined by immunohistochemistry and Western blot analysis, respectively (<xref ref-type="fig" rid="pone-0000827-g001">Fig. 1</xref>).</p><fig id="pone-0000827-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000827.g001</object-id><label>Figure 1</label><caption><title>Immunohistochemistry for TRPV4 in CAs (upper panel) and Western blot analysis of TRPV4 protein expression in kidneys (lower panel) of WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice.</title><p>Note the absence of specific staining in CA of TRPV4<sup>&#x02212;/&#x02212;</sup> mice. Me&#x0200a;&#x0003d;&#x0200a;media; Lu&#x0200a;&#x0003d;&#x0200a;lumen; En&#x0200a;&#x0003d;&#x0200a;endothelium. In a kidney extract obtained from WT mice, the anti-TRPV4 antibody detected a protein of &#x0223c;95 kDa, which is in good agreement with the calculated molecular weight (98 kDa). Furthermore, an additional band of &#x0223c;107 kDa, presumably representing the glycosylated protein, is detected by the antibody. In extracts from TRPV4<sup>&#x02212;/&#x02212;</sup> mice, no signals were present. Equal protein loading of the blots was validated by visualization of tubulin.</p></caption><graphic xlink:href="pone.0000827.g001"/></fig><p>In whole cell-patch clamp experiments, 4&#x003b1;PDD (1 &#x000b5;mol/L), a synthetic activator of TRPV4, gated moderately outward-rectifying currents in CAEC from WT mice (<xref ref-type="fig" rid="pone-0000827-g002">Fig. 2A</xref> left, E). Ruthenium red (RuR, 1 &#x000b5;mol/L, n&#x0200a;&#x0003d;&#x0200a;7), a blocker of TRPV channels, reduced inward currents to 10&#x000b1;3&#x00025; of the initial value, in a voltage-dependent fashion. 4&#x003b1;PDD-inducible currents were absent in CAEC from TRPV4<sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="pone-0000827-g002">Fig. 2A, right panel, E</xref>). Arachidonic acid (AA, 10 &#x000b5;mol/L) produced TRPV4 currents in CAEC of WT littermates, which were reduced by 40&#x000b1;5&#x00025; by 1 &#x000b5;mol/L RuR (n&#x0200a;&#x0003d;&#x0200a;5; <xref ref-type="fig" rid="pone-0000827-g002">Fig. 2B, left panel</xref>; E). In CAEC from TRPV4<sup>&#x02212;/&#x02212;</sup> mice, AA generated significantly smaller currents (<xref ref-type="fig" rid="pone-0000827-g002">Fig. 2B</xref>; right panel, E). Hypo-osmotic stress (HTS; 206 mosmol/L bath solution, leading to cell swelling and thus stretching of the plasma membrane) activated TRPV4-currents in CAEC of WT littermates (<xref ref-type="fig" rid="pone-0000827-g002">Fig. 2C, left panel</xref>). These currents were reduced to 35&#x000b1;5&#x00025; of the initial value by RuR (n&#x0200a;&#x0003d;&#x0200a;6; <xref ref-type="fig" rid="pone-0000827-g002">Fig. 2D, left panel</xref>). The remaining RuR-insensitive current was further reduced to 10&#x000b1;4&#x00025; by 10 &#x000b5;mol/L Gd<sup>3&#x0002b;</sup> (n&#x0200a;&#x0003d;&#x0200a;4), an unspecific inorganic blocker of mechanosensitive channels and a variety of other TRP channels <xref ref-type="bibr" rid="pone.0000827-Clapham1">&#x0005b;6&#x0005d;</xref>. HTS-induced currents were also observed in CAEC of TRPV4<sup>&#x02212;/&#x02212;</sup> mice (<xref ref-type="fig" rid="pone-0000827-g002">Fig. 2C, right panel</xref>), but the amplitude of these currents was significantly reduced compared to those in CAEC from WT animals (<xref ref-type="fig" rid="pone-0000827-g002">Fig. 2E</xref>). This smaller HTS-inducible current in CAEC from TRPV4<sup>&#x02212;/&#x02212;</sup> mice was insensitive to RuR, but could be decreased by 70&#x000b1;5&#x00025; by 10 &#x000b5;mol/L Gd<sup>3&#x0002b; </sup>(n&#x0200a;&#x0003d;&#x0200a;5; <xref ref-type="fig" rid="pone-0000827-g002">Fig. 2D, right panel</xref>), thus indicating that these currents are carried by other channels.</p><fig id="pone-0000827-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000827.g002</object-id><label>Figure 2</label><caption><title>Electrophysiological properties of TRPV4 currents in carotid artery endothelial cells (CAEC) from WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice.</title><p>A, left panel, Representative recording of 4&#x003b1;PDD (1 &#x000b5;mol/L)-inducible TRPV4-currents in CAEC of WT. Voltage-dependent inhibition by RuR (1 &#x000b5;mol/L). Right panel, 4&#x003b1;PDD-inducible currents were undetectable in CAEC of TRPV4<sup>&#x02212;/&#x02212;</sup> mice. B, left panel, Representative recording of AA (10 &#x000b5;mol/L)-inducible TRPV4 currents in CAEC of WT and inhibition by RuR (1 &#x000b5;mol/L). Right panel, small AA-inducible cation-currents in CAEC of TRPV4<sup>&#x02212;/&#x02212;</sup> mice. C, left panel, HTS (206 mosmol/L)-inducible TRPV4-currents in CAEC of WT. Right panel, HTS-inducible cation currents of smaller amplitude in CAEC of TRPV4<sup>&#x02212;/&#x02212;</sup> mice. D, left panel, Partial voltage-dependent inhibition of HTS-inducible TRPV4 currents in CAEC of WT and almost complete inhibition by the combination of RuR and Gd<sup>3&#x0002b;</sup> (10 &#x000b5;mol/L). Right panel, RuR insensitivity and Gd<sup>3&#x0002b;</sup> sensitivity of HTS-inducible cation currents in CAEC of TRPV4<sup>&#x02212;/&#x02212;</sup> mice. E, Mean 4&#x003b1;PDD-, AA-, and HTS-inducible TRPV4 and other cation currents in CAEC of WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice. Numbers in brackets indicate the number of cells investigated. Values are given as means&#x000b1;SEM; &#x0002a; P&#x0003c;0.05, &#x0002a;&#x0002a; P&#x0003c;0.01, <italic>t</italic> test.</p></caption><graphic xlink:href="pone.0000827.g002"/></fig><p>In aggregate, these electrophysiological properties of TRPV4 currents in CAEC of WT mice resemble the characteristics of endothelial TRPV4 from rat carotid artery <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref> and mouse aorta <xref ref-type="bibr" rid="pone.0000827-Vriens1">&#x0005b;18&#x0005d;</xref>. The complete loss of 4&#x003b1;PDD-induced currents in CAEC from TRPV4<sup>&#x02212;/&#x02212;</sup> mice demonstrates the functional expression of TRPV4 in carotid endothelia and also implies that 4&#x003b1;PDD appears to be capable of selectively activating TRPV4 in WT cells. The severely diminished HTS- and AA-induced currents in CAEC from TRPV4<sup>&#x02212;/&#x02212;</sup> mice show that indeed the majority of these currents in WT are carried by endothelial TRPV4. Similar findings were obtained from mouse aortic endothelial cells <xref ref-type="bibr" rid="pone.0000827-Vriens1">&#x0005b;18&#x0005d;</xref> derived from another TRPV4<sup>&#x02212;/&#x02212;</sup> strain <xref ref-type="bibr" rid="pone.0000827-Suzuki1">&#x0005b;30&#x0005d;</xref>, in which TRPV4-activating stimuli such as 4&#x003b1;PDD, AA, AA-metabolites (EETs) and HTS did not produce TRPV4-like currents and TRPV4-associated Ca<sup>2&#x0002b;</sup>-responses <xref ref-type="bibr" rid="pone.0000827-Vriens1">&#x0005b;18&#x0005d;</xref>. In extension of these findings, we show here that a small residual AA and HTS-inducible cation current, insensitive to RuR but sensitive to Gd<sup>3&#x0002b;</sup>, points to a minor contribution of other yet unidentified AA-sensitive cationic channels and/or HTS-sensitive mechanosensitive channels. In keeping with the RuR-insensitivity of such currents, it appears likely that the deficiency of TRPV4 is not compensated by other closely related members of the TRPV subfamily, such as TRPV1 and TRPV2, which do not seem to be expressed in normal carotid endothelia <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref>. In carotid endothelium of either TRPV4<sup>&#x0002b;/&#x0002b;</sup> or TRPV4<sup>&#x02212;/&#x02212;</sup> mice, TRPV1 does not seem to be considerably expressed and, likewise, the TRPV1 opener capsaicin (1 &#x000b5;mol/L) did not produce endothelium-dependent vasodilation (data not shown). Recently, it has been reported that a member of the two-pore K<sup>&#x0002b;</sup> family of channels, TREK-1 <xref ref-type="bibr" rid="pone.0000827-Patel1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Garry1">&#x0005b;40&#x0005d;</xref>, bears a functional resemblance to TRPV4 and could, thus, be a candidate to substitute for the loss of TRPV4. TREK-1 functions were similar in CAEC of both genotypes (unpublished observation by our group). Thus, these observations further support the idea that loss of TRPV4 is not compensated by other TRPV or TREK channels.</p></sec><sec id="s3b"><title>Vascular compliance in TRPV4<sup>&#x02212;/&#x02212;</sup> mice</title><p>To evaluate the functional role of TRPV4 in the endothelium, we performed pressure myograph experiments in CA from WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice. In the presence or absence of NO- and cyclooxygenase inhibitors (L-NNA and INDO), the basal (passive) diameter of CA (pressurized to 80 mmHg) from TRPV4<sup>&#x02212;/&#x02212;</sup> mice and WT littermates did not differ (<xref ref-type="fig" rid="pone-0000827-g003">Fig. 3A and B</xref>). The constriction in response to either phenylephrine (PE, 1 &#x000b5;mol/L and below) (<xref ref-type="fig" rid="pone-0000827-g003">Fig. 3A, B, and C</xref>) or to 60 mmol/L K<sup>&#x0002b;</sup> (<xref ref-type="fig" rid="pone-0000827-g003">Fig. 3A and B</xref>) in TRPV4<sup>&#x02212;/&#x02212;</sup> and WT mice was not statistically different. The vasodilation elicited by sodium nitro prusside (SNP, 10 &#x000b5;mol/L) was similar in both groups (<xref ref-type="fig" rid="pone-0000827-g003">Fig. 3A and B</xref>), which thus suggests that TRPV4 deficiency does not compromise endothelium-independent relaxation of smooth muscle. In addition, TRPV4<sup>&#x02212;/&#x02212; </sup>CA and WT CA exhibited a similar passive increase in CA diameter in response to increasing intravascular pressure (range 0&#x02013;140 mmHg) and in the presence of SNP (to eliminate any myogenic constriction (Bayliss effect) (<xref ref-type="fig" rid="pone-0000827-g003">Fig. 3D</xref>). These results indicate that total vascular compliance, elasticity and response to static mechanical pressure from within the lumen of the CA are unaffected by TRPV4 deficiency.</p><fig id="pone-0000827-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000827.g003</object-id><label>Figure 3</label><caption><title>Compliance of carotid arteries (CA) of WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice.</title><p>A and B, Diameter of CA pressurized to 80 mmHg (basal) and in the extravascular presence of PE, K<sup>&#x0002b;</sup>, and SNP in the absence and presence of L-NNA (300 &#x000b5;mol/L) and INDO (10 &#x000b5;mol/L); WT CA, -L-NNA/INDO: n&#x0200a;&#x0003d;&#x0200a;11 and&#x0002b;L-NNA/INDO: n&#x0200a;&#x0003d;&#x0200a;8; TRPV4<sup>&#x02212;/&#x02212;</sup> CA, -L-NNA/INDO: n&#x0200a;&#x0003d;&#x0200a;7 and&#x0002b;L-NNA/INDO: n&#x0200a;&#x0003d;&#x0200a;8. C, PE-induced contraction of CA from WT (CA, n&#x0200a;&#x0003d;&#x0200a;4) and TRPV4<sup>&#x02212;/&#x02212;</sup> mice (CA, n&#x0200a;&#x0003d;&#x0200a;4) in the presence of L-NNA and INDO. D, Change in passive diameter (normalized to body weight) of CA from WT (CA, n&#x0200a;&#x0003d;&#x0200a;13) and TRPV4<sup>&#x02212;/&#x02212;</sup> mice (CA, n&#x0200a;&#x0003d;&#x0200a;10) in response to increasing intravascular pressure and in the presence of SNP. Values are given as means&#x000b1;SEM.</p></caption><graphic xlink:href="pone.0000827.g003"/></fig></sec><sec id="s3c"><title>Loss of 4&#x003b1;PDD-induced vasodilation in TRPV4<sup>&#x02212;/&#x02212;</sup> mice</title><p>Intraluminal application of 4&#x003b1;PDD (1 &#x000b5;mol/L) caused a robust vasodilation of CA (&#x0223c;60&#x00025;) in WT mice (<xref ref-type="fig" rid="pone-0000827-g004">Fig. 4A</xref>) which was completely absent if 4&#x003b1;PDD was applied together with the TRPV-blocker RuR (1 &#x000b5;mol/L, data not shown). In addition, we tested whether 4&#x003b1;PDD causes EDHF-type vasodilation of WT CA. EDHF-mediated vasodilation is defined as the vasodilation caused by endothelium-dependent hyperpolarization of smooth muscle, which is resistant to inhibitors of NO-synthase and cyclooxygenase. In the presence of both inhibitors, 4&#x003b1;PDD-induced vasodilation was reduced to &#x0223c;40&#x00025; of the value obtained without such inhibitors (<xref ref-type="fig" rid="pone-0000827-g004">Fig. 4A</xref>). This results indicates that pharmacological activation of endothelial TRPV4 leads to vasodilation, which is partly caused by an EDHF-type signaling in mouse CA (<xref ref-type="fig" rid="pone-0000827-g004">Fig. 4A</xref>), and this is similar to what we observed previously in small arteries from the rat gracilis muscle. However, the 4&#x003b1;PDD-induced response was more pronounced in the murine CA than in the rat CA, in which overall EDHF-signaling is weaker than in murine CA <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Si1">&#x0005b;41&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Eichler1">&#x0005b;42&#x0005d;</xref>.</p><fig id="pone-0000827-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000827.g004</object-id><label>Figure 4</label><caption><title>4&#x003b1;PDD and ACh-induced vasodilation in CA of WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice.</title><p>A, 4&#x003b1;PDD (1 &#x000b5;mol/L)-induced vasodilation in CA of WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice in the absence and presence of L-NNA and INDO. WT CA, -L-NNA/INDO: n&#x0200a;&#x0003d;&#x0200a;12 and&#x0002b;L-NNA/INDO: n&#x0200a;&#x0003d;&#x0200a;9; TRPV4<sup>&#x02212;/&#x02212;</sup> CA, -L-NNA/INDO: n&#x0200a;&#x0003d;&#x0200a;6 and&#x0002b;L-NNA/INDO: n&#x0200a;&#x0003d;&#x0200a;8. B, ACh-induced vasodilation in CA of WT (n&#x0200a;&#x0003d;&#x0200a;7) and TRPV4<sup>&#x02212;/&#x02212;</sup> (n&#x0200a;&#x0003d;&#x0200a;6) in the absence of L-NNA and INDO and B, in their presence; WT CA (n&#x0200a;&#x0003d;&#x0200a;6); TRPV4<sup>&#x02212;/&#x02212;</sup> CA (n&#x0200a;&#x0003d;&#x0200a;6). &#x0002a; P&#x0003c;0.001, <italic>t</italic> test.</p></caption><graphic xlink:href="pone.0000827.g004"/></fig><p>In murine CA, this 4&#x003b1;PDD-induced EDHF-type vasodilator response was almost abolished by inhibition of endothelial SK<sub>Ca</sub> and IK<sub>Ca</sub> channels, the underlying effectors of the EDHF signal in these arteries <xref ref-type="bibr" rid="pone.0000827-Si1">&#x0005b;41&#x0005d;</xref>, with UCL 1684 (1 &#x000b5;mol/L) <xref ref-type="bibr" rid="pone.0000827-Rosa1">&#x0005b;43&#x0005d;</xref> and TRAM-34 (1 &#x000b5;mol/L) <xref ref-type="bibr" rid="pone.0000827-Wulff1">&#x0005b;44&#x0005d;</xref> (<xref ref-type="supplementary-material" rid="pone.0000827.s001">Figure S1</xref>). Moreover, this EDHF-type response, as well as the NO/PGI<sub>2</sub>-dependent component, was eliminated after preloading the endothelium with the Ca<sup>2&#x0002b;</sup>-chelator BAPTA-AM to eliminate endothelial Ca<sup>2&#x0002b;</sup> signaling (<xref ref-type="supplementary-material" rid="pone.0000827.s001">Figure S1</xref>). This clearly shows that activation of TRPV4 by application of 4&#x003b1;PDD induces vasodilation which critically depends on an increase of intracellular Ca<sup>2&#x0002b;</sup> within the endothelium.</p><p>In striking difference to the WT, a vasodilator-response to 4&#x003b1;PDD could not be observed in TRPV4<sup>&#x02212;/&#x02212;</sup> mice, neither in the absence nor in the presence of NO- and cyclooxygenase inhibitors (<xref ref-type="fig" rid="pone-0000827-g004">Fig. 4A</xref>). This strongly suggests that 4&#x003b1;PDD-induced vasodilation in WT mice is mediated by TRPV4, and, in view of the robust amplitude of this vasodilator response, that TRPV4 plays a central role in endothelium-dependent regulation of vascular tone.</p></sec><sec id="s3d"><title>Total acetylcholine-induced vasodilation and EDHF-mediated vasodilation is intact in TRPV4<sup>&#x02212;/&#x02212;</sup> mice</title><p>Total acetylcholine-induced vasodilation (in the absence of NO-synthase and cyclooxygenase inhibitors) was unchanged in TRPV4<sup>&#x02212;/&#x02212;</sup> mice vs. WT (<xref ref-type="fig" rid="pone-0000827-g004">Fig. 4B</xref>). This was also true for EDHF-mediated vasodilation (<xref ref-type="fig" rid="pone-0000827-g004">Fig. 4C</xref>). These data show that TRPV4 is not appreciably involved in acetylcholine-induced and either NO or EDHF-mediated vasodilation. Thus, TRPV4 does not play a role in endothelial agonist-induced and G-protein-coupled receptor-operated Ca<sup>2&#x0002b;</sup> mobilization and -entry in this conduit artery.</p></sec><sec id="s3e"><title>Loss of shear stress-induced vasodilation in TRPV4<sup>&#x02212;/&#x02212;</sup> mice</title><p>The reported mechanosensitivity of TRPV4 channels <xref ref-type="bibr" rid="pone.0000827-ONeil1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Liedtke2">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-AlessandriHaber1">&#x0005b;25&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Gao1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Grant1">&#x0005b;34&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Mutai1">&#x0005b;45&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-AlessandriHaber3">&#x0005b;46&#x0005d;</xref> and the sensitivity of shear stress-induced vasodilation of rat CA and gracilis artery <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref> to the TRPV blocker RuR indicate a possible role for TRPV4 in endothelial mechanotransduction.</p><p>To compare shear stress-mediated vasodilation between TRPV4<sup>&#x02212;/&#x02212;</sup> mice and WT littermates, the viscosity of the perfusion medium was increased by addition of 5&#x00025; dextran, resulting in a physiologically relevant increase in shear stress from &#x0223c;3 to 7 dyn/cm<sup>2</sup>. In WT mice, the increase in viscosity elicited a vasodilation of &#x0223c;20&#x00025; in the absence of NO- and cyclooxygenase inhibitors (<xref ref-type="fig" rid="pone-0000827-g005">Fig. 5A</xref>). Inhibition of cyclooxygenases did not reduce this response suggesting that prostacyclin production does not contribute to this vasodilator response (data not shown). In the presence of both inhibitors, the increase in shear stress resulted in a diminished vasodilation of &#x0223c;10&#x00025;, exclusively mediated by the EDHF system (<xref ref-type="fig" rid="pone-0000827-g005">Fig. 5A</xref>). This EDHF-type vasodilator response was almost abolished by inhibition of endothelial SK<sub>Ca</sub> and IK<sub>Ca</sub> channels (<xref ref-type="supplementary-material" rid="pone.0000827.s002">Figure S2</xref>). Buffering of endothelial Ca<sup>2&#x0002b;</sup> greatly attenuated both the EDHF response alone, as well as the composite NO/EDHF response (<xref ref-type="supplementary-material" rid="pone.0000827.s002">Figure S2</xref>), a similar effect to that on 4&#x003b1;PDD responses. Like shear stress-induced vasodilation in small and large arteries of the rat <xref ref-type="bibr" rid="pone.0000827-Khler2">&#x0005b;17&#x0005d;</xref>, murine CA vasodilation was blocked by the TRPV inhibitor RuR or by pre-incubation with 3 &#x000b5;mol/L AACOCF<sub>3</sub> (<xref ref-type="supplementary-material" rid="pone.0000827.s002">Figure S2</xref>) to prevent the release of AA and production of AA metabolites, the putative endogenous activators of TRPV4 <xref ref-type="bibr" rid="pone.0000827-Vriens1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Watanabe1">&#x0005b;19&#x0005d;</xref>. This dependency on PLA<sub>2</sub> activity - also shown by others recently <xref ref-type="bibr" rid="pone.0000827-Marrelli1">&#x0005b;20&#x0005d;</xref> - possibly implies that products of PLA<sub>2</sub> can enhance the mechanotransductory function of TRPV4. Alternatively, TRPV4 channels may not function directly as the mechanosensor, rather as critical components of down-stream signaling (reviewed in Liedtke and Kim 2005).</p><fig id="pone-0000827-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0000827.g005</object-id><label>Figure 5</label><caption><title>Shear stress- and flow/reperfusion-induced vasodilation in CA of WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice.</title><p>A, Shear stress-induced vasodilation in CA of WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice in the absence and presence of L-NNA and INDO; WT CA, n&#x0200a;&#x0003d;&#x0200a;12 and n&#x0200a;&#x0003d;&#x0200a;9; TRPV4<sup>&#x02212;/&#x02212;</sup> CA, n&#x0200a;&#x0003d;&#x0200a;6 and n&#x0200a;&#x0003d;&#x0200a;8, respectively. Shear stress-induced vasodilation was elicited by switching to a perfusion medium containing 5&#x00025; dextran (5&#x00025; Dex). B, Flow/reperfusion-induced vasodilation of CA of WT and TRPV4<sup>&#x02212;/&#x02212;</sup> mice in the absence and presence of L-NNA and INDO. WT CA, n&#x0200a;&#x0003d;&#x0200a;9 and n&#x0200a;&#x0003d;&#x0200a;8; TRPV4<sup>&#x02212;/&#x02212;</sup> CA, n&#x0200a;&#x0003d;&#x0200a;7 and n&#x0200a;&#x0003d;&#x0200a;7, respectively. &#x0002a; P&#x0003c;0.05, &#x0002a;&#x0002a; P&#x0003c;0.01, <italic>t</italic> test.</p></caption><graphic xlink:href="pone.0000827.g005"/></fig><p>Strikingly, in TRPV4<sup>&#x02212;/&#x02212;</sup> mice, the dextran-mediated increase in shear stress did not cause any NO or EDHF-mediated vasodilation, but rather resulted in a subtle, yet appreciable vasoconstriction (<xref ref-type="fig" rid="pone-0000827-g005">Fig. 5A</xref>). This complete loss of shear stress-induced vasodilation in TRPV4<sup>-/&#x02212; </sup>mice demonstrates that Ca<sup>2&#x0002b;</sup>-entry through TRPV4 is a crucial step in endothelial mechanotransduction in response to shear stress, not compensated by any other gene in the absence of TRPV4.</p><p>In the present study, we go on to demonstrate that CA of TRPV4<sup>&#x02212;/&#x02212;</sup> mice exhibit an altered vasodilation in response to re-establishing flow through the vessel (reperfusion) from almost static conditions (30 &#x000b5;l/ml) to physiologically relevant levels (600 &#x000b5;l/ml), when compared to WT littermates. In general, flow-evoked vasodilation is a complex Ca<sup>2&#x0002b;</sup>-dependent (as well as possibly Ca<sup>2&#x0002b;</sup>-independent), NO- and EDHF-mediated and strictly endothelium-dependent process <xref ref-type="bibr" rid="pone.0000827-Falcone1">&#x0005b;47&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0000827-Fleming1">&#x0005b;49&#x0005d;</xref>, which in these respects is remarkably similar to shear-stress induced vasodilation. In WT mice, the onset of flow, as happens in reperfusion, caused vasodilation of &#x0223c;30&#x00025; in the absence of NO- and cyclooxygenase inhibitors (<xref ref-type="fig" rid="pone-0000827-g005">Fig. 5B</xref>). Similar to shear stress-induced vasodilator responses, this flow/reperfusion-evoked vasodilation was on average reduced to &#x0223c;10&#x00025; in the presence NO and cyclooxygenase inhibitors (<xref ref-type="fig" rid="pone-0000827-g005">Fig. 5B</xref>), thus indicating a partial contribution of the EDHF system. Consequently, dual inhibition of endothelial SK<sub>Ca</sub> and IK<sub>Ca</sub> channels eliminated this EDHF response (<xref ref-type="supplementary-material" rid="pone.0000827.s003">Figure S3</xref>). Inhibition of cyclooxygenases alone did not diminish this response suggesting that prostacyclin production does not add further to this flow/reperfusion-induced vasodilation in the murine carotid artery (data not shown). Again, like for shear stress and 4&#x003b1;PDD responses, buffering of endothelial Ca<sup>2&#x0002b;</sup> virtually eliminated the EDHF response alone and greatly reduced the composite NO/EDHF response (<xref ref-type="supplementary-material" rid="pone.0000827.s003">Figure S3</xref>). Moreover, inhibition of PLA<sub>2</sub> by AACOCF<sub>3</sub> abolished flow/reperfusion-induced and NO/EDHF-mediated vasodilation (<xref ref-type="supplementary-material" rid="pone.0000827.s003">Figure S3</xref>), thus indicating that the release of AA and generation of AA metabolites, possibly functioning as (direct or indirect) endogenous modulators of TRPV4, are also important in this type of vasodilation.</p><p>In CA of TRPV4<sup>&#x02212;/&#x02212;</sup> mice vs. WT, flow/reperfusion resulted in a significantly reduced vasodilation of &#x0223c;15&#x00025; and &#x0223c;5&#x00025; in the absence and presence of NO and cyclooxygenase inhibitors, respectively (<xref ref-type="fig" rid="pone-0000827-g005">Fig. 5B</xref>). Therefore, these data suggest that TRPV4 also participates critically in flow/reperfusion-induced vasodilation, which, however, in contrast to shear stress-induced vasodilation, is not completely dependent on TRPV4 and may involve other Ca<sup>2&#x0002b;</sup>-dependent or possibly Ca<sup>2&#x0002b;</sup>-independent mechanisms <xref ref-type="bibr" rid="pone.0000827-Fleming1">&#x0005b;49&#x0005d;</xref>.</p><p>In conclusion, we used genetically engineered TRPV4<sup>&#x02212;/&#x02212;</sup> mice to demonstrate the absolute dependence of vasodilation in response to physiologically relevant shear stress on endothelial TRPV4 and a significant contribution of TRPV4 to flow/reperfusion-induced vasodilation. These novel findings are based on the following facts: (1) The TRPV4-activator 4&#x003b1;PDD dilated WT CAs, a response-pattern completely absent in TRPV4<sup>&#x02212;/&#x02212;</sup>. (2) Shear stress-induced vasodilation was also completely absent in TRPV4<sup>&#x02212;/&#x02212;</sup> mice. (3) Flow/reperfusion-induced vasodilation was greatly diminished in TRPV4<sup>&#x02212;/&#x02212;</sup> mice. In contrast, smooth-muscle dependent SNP-mediated vasodilation and acetylcholine-induced vasodilation did not differ between TRPV4<sup>&#x02212;/&#x02212;</sup> and WT mice, reiterating the specificity of our findings (1&#x02013;3). Based on our observations, a novel concept emanates, namely that mechanical activation of TRPV4 in arteries by physiologically relevant shear stress and flow/reperfusion is a critical component of endothelial mechanotransduction.</p><p>On a final note, this novel role of TRPV4 not only advances our basic understanding of vascular physiology, it also renders TRPV4 an appealing target <xref ref-type="bibr" rid="pone.0000827-Gudermann1">&#x0005b;50&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0000827-Wissenbach1">&#x0005b;51&#x0005d;</xref> for therapeutic manipulation of arterial diameter, e.g. in cardiovascular disease states like hypertension <xref ref-type="bibr" rid="pone.0000827-Maier1">&#x0005b;52&#x0005d;</xref>, ischemia-reperfusion-induced vascular injury, and, last but not least, in atherosclerosis, where chronic mechanical shear stress and inappropriate endothelial Ca<sup>2&#x0002b;</sup> influx have been suggested to be pathogenic for regional lesion development and progression (e.g. at the carotid bifurcation). For atherosclerosis, it is tempting to speculate that the inflammatory component of the process sensitizes endothelial TRPV4 via cytokine-mechanisms <xref ref-type="bibr" rid="pone.0000827-AlessandriHaber1">&#x0005b;25&#x0005d;</xref>. At least as attractive, and not mutually exclusive is the hypothesis that arterial injury, like in early atherosclerosis, will up-regulate endothelial expression of proteinase-activated-receptor 2 <xref ref-type="bibr" rid="pone.0000827-Fukunaga1">&#x0005b;53&#x0005d;</xref>, which will be activated proteolytically within the atherosclerotic lesion and via systemic proteases to specifically sensitize endothelial TRPV4 channels to respond to mechanical stress <xref ref-type="bibr" rid="pone.0000827-Grant1">&#x0005b;34&#x0005d;</xref>.</p></sec></sec><sec sec-type="supplementary-material" id="s4"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0000827.s001"><label>Figure S1</label><caption><p>Pharmacological properties of 4&#x003b1;PDD-induced vasodilation in murine CA. From left to right: Inhibition of EDHF-type responses (in the presence of L-NNA and INDO) by the combination of IK<sup>Ca</sup>/SK<sup>Ca</sup>-blockers (TRAM-34 (1 &#x000b5;mol/L) and UCL 1684 (1 &#x000b5;mol/L); n&#x0200a;&#x0003d;&#x0200a;4) and after preloading the endothelium with BAPTA-AM (10 &#x000b5;mol/L; n&#x0200a;&#x0003d;&#x0200a;6) for 10 min to buffer intracellular Ca<sup>2&#x0002b;</sup>. Inhibition of composite NO/EDHF-type responses (in the absence of L-NNA and INDO) by BAPTA-AM (n&#x0200a;&#x0003d;&#x0200a;4). For controls (ctrl, white bars), values&#x000b1;SEM are given in <xref ref-type="fig" rid="pone-0000827-g004">figure 4</xref>. &#x0002a; P&#x0003c;0.05, t test.</p><p>(0.12 MB TIF)</p></caption><media xlink:href="pone.0000827.s001.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000827.s002"><label>Figure S2</label><caption><p>Pharmacological properties of shear stress-induced vasodilation in murine CA. From left to right: Inhibition of shear stress (Dex 5&#x00025;)-induced EDHF-type responses by IK<sup>Ca</sup>/SK<sup>Ca</sup> blockers (n&#x0200a;&#x0003d;&#x0200a;11), after buffering of endothelial intracellular Ca<sup>2&#x0002b;</sup> with BAPTA-AM (n&#x0200a;&#x0003d;&#x0200a;7). Inhibition of composite NO/EDHF-type responses by BAPTA-AM (n&#x0200a;&#x0003d;&#x0200a;8), the TRPV4 blocker RuR (1 &#x000b5;mol/L; n&#x0200a;&#x0003d;&#x0200a;4), and by the PLA<sup>2</sup> inhibitor AACOCF<sup>3</sup> (3 &#x000b5;mol/L; n&#x0200a;&#x0003d;&#x0200a;4). For controls (ctrl, white bars), values&#x000b1;SEM are given in <xref ref-type="fig" rid="pone-0000827-g005">figure 5</xref> A. &#x0002a; P&#x0003c;0.05, t test.</p><p>(0.10 MB TIF)</p></caption><media xlink:href="pone.0000827.s002.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0000827.s003"><label>Figure S3</label><caption><p>Pharmacological properties of flow/reperfusion-induced vasodilation in murine CA. From left to right: Inhibition of EDHF-type responses by IK<sup>Ca</sup>/SK<sup>Ca</sup> blockers (n&#x0200a;&#x0003d;&#x0200a;5), after buffering of endothelial intracellular Ca<sup>2&#x0002b;</sup> with BAPTA-AM (n&#x0200a;&#x0003d;&#x0200a;3). Inhibition of composite NO/EDHF-type responses by BAPTA-AM (n&#x0200a;&#x0003d;&#x0200a;7), and by the PLA<sup>2</sup> inhibitor AACOCF<sup>3</sup> (n&#x0200a;&#x0003d;&#x0200a;8). For controls (ctrl, white bars), values&#x000b1;SEM are given in <xref ref-type="fig" rid="pone-0000827-g005">figure 5</xref> B. &#x0002a; P&#x0003c;0.05, t test.</p><p>(0.12 MB TIF)</p></caption><media xlink:href="pone.0000827.s003.tif" mimetype="image" mime-subtype="tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We wish to thank Tim D. Plant for helpful comments on the manuscript.</p></ack><ref-list><title>References</title><ref id="pone.0000827-Furchgott1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furchgott</surname><given-names>RF</given-names></name><name><surname>Zawadzki</surname><given-names>JV</given-names></name></person-group><year>1980</year><article-title>The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.</article-title><source>Nature</source><volume>288</volume><fpage>373</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">6253831</pub-id></citation></ref><ref id="pone.0000827-Moncada1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moncada</surname><given-names>S</given-names></name><name><surname>Gryglewski</surname><given-names>R</given-names></name><name><surname>Bunting</surname><given-names>S</given-names></name><name><surname>Vane</surname><given-names>JR</given-names></name></person-group><year>1976</year><article-title>An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.</article-title><source>Nature</source><volume>263</volume><fpage>663</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">802670</pub-id></citation></ref><ref id="pone.0000827-Nilius1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nilius</surname><given-names>B</given-names></name><name><surname>Droogmans</surname><given-names>G</given-names></name></person-group><year>2001</year><article-title>Ion channels and their functional role in vascular endothelium.</article-title><source>Physiol Rev</source><volume>81</volume><fpage>1415</fpage><lpage>1459</lpage><pub-id pub-id-type="pmid">11581493</pub-id></citation></ref><ref id="pone.0000827-Feletou1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feletou</surname><given-names>M</given-names></name><name><surname>Vanhoutte</surname><given-names>PM</given-names></name></person-group><year>2006</year><article-title>Endothelium-derived hyperpolarizing factor: where are we now?</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>26</volume><fpage>1215</fpage><lpage>1225</lpage><pub-id pub-id-type="pmid">16543495</pub-id></citation></ref><ref id="pone.0000827-Khler1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>R</given-names></name><name><surname>Hoyer</surname><given-names>J</given-names></name></person-group><year>2007</year><article-title>The endothelium-derived hyperpolarizing factor: insights from genetic animal models.</article-title><source>Kidney Int Apr</source><volume>25; &#x0005b;Epub ahead of print&#x0005d;; doi:10.1038/sj.ki.5002303</volume></citation></ref><ref id="pone.0000827-Clapham1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clapham</surname><given-names>DE</given-names></name><name><surname>Montell</surname><given-names>C</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name><name><surname>Julius</surname><given-names>D</given-names></name></person-group><year>2003</year><article-title>International Union of Pharmacology. XLIII. Compendium of voltage-gated ion channels: transient receptor potential channels.</article-title><source>Pharmacol Rev</source><volume>55</volume><fpage>591</fpage><lpage>596</lpage><pub-id pub-id-type="pmid">14657417</pub-id></citation></ref><ref id="pone.0000827-Nilius2"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nilius</surname><given-names>B</given-names></name><name><surname>Droogmans</surname><given-names>G</given-names></name><name><surname>Wondergem</surname><given-names>R</given-names></name></person-group><year>2003</year><article-title>Transient receptor potential channels in endothelium: solving the calcium entry puzzle?</article-title><source>Endothelium</source><volume>10</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">12699072</pub-id></citation></ref><ref id="pone.0000827-Harteneck1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harteneck</surname><given-names>C</given-names></name><name><surname>Plant</surname><given-names>TD</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name></person-group><year>2000</year><article-title>From worm to man: three subfamilies of TRP channels.</article-title><source>Trends Neurosci</source><volume>23</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">10717675</pub-id></citation></ref><ref id="pone.0000827-Montell1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Montell</surname><given-names>C</given-names></name></person-group><year>2005</year><article-title>The TRP superfamily of cation channels.</article-title><source>Sci STKE</source><volume>2005</volume><fpage>re3</fpage><pub-id pub-id-type="pmid">15728426</pub-id></citation></ref><ref id="pone.0000827-Caterina1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caterina</surname><given-names>MJ</given-names></name></person-group><year>2007</year><article-title>Transient receptor potential ion channels as participants in thermosensation and thermoregulation.</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><volume>292</volume><fpage>R64</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">16973931</pub-id></citation></ref><ref id="pone.0000827-Flockerzi1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Flockerzi</surname><given-names>V</given-names></name></person-group><year>2007</year><article-title>An introduction on TRP channels.</article-title><source>Handb Exp Pharmacol</source><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">17217048</pub-id></citation></ref><ref id="pone.0000827-Trebak1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trebak</surname><given-names>M</given-names></name><name><surname>Lemonnier</surname><given-names>L</given-names></name><name><surname>Smyth</surname><given-names>JT</given-names></name><name><surname>Vazquez</surname><given-names>G</given-names></name><name><surname>Putney</surname><given-names>JW</given-names><suffix>Jr</suffix></name></person-group><year>2007</year><article-title>Phospholipase C-coupled receptors and activation of TRPC channels.</article-title><source>Handb Exp Pharmacol</source><fpage>593</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">17217081</pub-id></citation></ref><ref id="pone.0000827-Liedtke1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liedtke</surname><given-names>W</given-names></name></person-group><year>2007</year><article-title>TRPV channels' role in osmotransduction and mechanotransduction.</article-title><source>Handb Exp Pharmacol</source><fpage>473</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">17217074</pub-id></citation></ref><ref id="pone.0000827-ONeil1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Neil</surname><given-names>RG</given-names></name><name><surname>Heller</surname><given-names>S</given-names></name></person-group><year>2005</year><article-title>The mechanosensitive nature of TRPV channels.</article-title><source>Pfl&#x000fc;gers Arch</source><volume>451</volume><fpage>193</fpage><lpage>203</lpage></citation></ref><ref id="pone.0000827-Oancea1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oancea</surname><given-names>E</given-names></name><name><surname>Wolfe</surname><given-names>JT</given-names></name><name><surname>Clapham</surname><given-names>DE</given-names></name></person-group><year>2006</year><article-title>Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow.</article-title><source>Circ Res</source><volume>98</volume><fpage>245</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">16357306</pub-id></citation></ref><ref id="pone.0000827-Liedtke2"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liedtke</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name></person-group><year>2005</year><article-title>Functionality of the TRPV subfamily of TRP ion channels: add mechano-TRP and osmo-TRP to the lexicon!</article-title><source>Cell Mol Life Sci</source><volume>62</volume><fpage>2985</fpage><lpage>3001</lpage><pub-id pub-id-type="pmid">16314934</pub-id></citation></ref><ref id="pone.0000827-Khler2"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>R</given-names></name><name><surname>Heyken</surname><given-names>WT</given-names></name><name><surname>Heinau</surname><given-names>P</given-names></name><name><surname>Schubert</surname><given-names>R</given-names></name><name><surname>Si</surname><given-names>H</given-names></name><etal/></person-group><year>2006</year><article-title>Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation.</article-title><source>Arterioscler Thromb Vasc Biol</source><volume>26</volume><fpage>1495</fpage><lpage>1502</lpage><pub-id pub-id-type="pmid">16675722</pub-id></citation></ref><ref id="pone.0000827-Vriens1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vriens</surname><given-names>J</given-names></name><name><surname>Owsianik</surname><given-names>G</given-names></name><name><surname>Fisslthaler</surname><given-names>B</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Janssens</surname><given-names>A</given-names></name><etal/></person-group><year>2005</year><article-title>Modulation of the Ca<sup>2&#x0002b;</sup> permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.</article-title><source>Circ Res</source><volume>97</volume><fpage>908</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">16179585</pub-id></citation></ref><ref id="pone.0000827-Watanabe1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Vriens</surname><given-names>J</given-names></name><name><surname>Prenen</surname><given-names>J</given-names></name><name><surname>Droogmans</surname><given-names>G</given-names></name><name><surname>Voets</surname><given-names>T</given-names></name><etal/></person-group><year>2003</year><article-title>Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.</article-title><source>Nature</source><volume>424</volume><fpage>434</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">12879072</pub-id></citation></ref><ref id="pone.0000827-Marrelli1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marrelli</surname><given-names>SP</given-names></name><name><surname>O'Neil</surname><given-names>RG</given-names></name><name><surname>Brown</surname><given-names>RC</given-names></name><name><surname>Bryan</surname><given-names>RM</given-names><suffix>Jr</suffix></name></person-group><year>2007</year><article-title>PLA2 and TRPV4 channels regulate endothelial calcium in cerebral arteries.</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>292</volume><fpage>H1390</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">17071727</pub-id></citation></ref><ref id="pone.0000827-Watanabe2"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Davis</surname><given-names>JB</given-names></name><name><surname>Smart</surname><given-names>D</given-names></name><name><surname>Jerman</surname><given-names>JC</given-names></name><name><surname>Smith</surname><given-names>GD</given-names></name><etal/></person-group><year>2002</year><article-title>Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>13569</fpage><lpage>13577</lpage><pub-id pub-id-type="pmid">11827975</pub-id></citation></ref><ref id="pone.0000827-Andrade1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>YN</given-names></name><name><surname>Fernandes</surname><given-names>J</given-names></name><name><surname>Vazquez</surname><given-names>E</given-names></name><name><surname>Fernandez-Fernandez</surname><given-names>JM</given-names></name><name><surname>Arniges</surname><given-names>M</given-names></name><etal/></person-group><year>2005</year><article-title>TRPV4 channel is involved in the coupling of fluid viscosity changes to epithelial ciliary activity.</article-title><source>J Cell Biol</source><volume>168</volume><fpage>869</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">15753126</pub-id></citation></ref><ref id="pone.0000827-Strotmann1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strotmann</surname><given-names>R</given-names></name><name><surname>Harteneck</surname><given-names>C</given-names></name><name><surname>Nunnenmacher</surname><given-names>K</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name><name><surname>Plant</surname><given-names>TD</given-names></name></person-group><year>2000</year><article-title>OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity.</article-title><source>Nat Cell Biol</source><volume>2</volume><fpage>695</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">11025659</pub-id></citation></ref><ref id="pone.0000827-Liedtke3"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liedtke</surname><given-names>W</given-names></name><name><surname>Friedman</surname><given-names>JM</given-names></name></person-group><year>2003</year><article-title>Abnormal osmotic regulation in trpv4<sup>&#x02212;/&#x02212;</sup> mice.</article-title><source>Proc Natl Acad Sci U S A</source><volume>100</volume><fpage>13698</fpage><lpage>13703</lpage><pub-id pub-id-type="pmid">14581612</pub-id></citation></ref><ref id="pone.0000827-AlessandriHaber1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alessandri-Haber</surname><given-names>N</given-names></name><name><surname>Dina</surname><given-names>OA</given-names></name><name><surname>Joseph</surname><given-names>EK</given-names></name><name><surname>Reichling</surname><given-names>D</given-names></name><name><surname>Levine</surname><given-names>JD</given-names></name></person-group><year>2006</year><article-title>A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators.</article-title><source>J Neurosci</source><volume>26</volume><fpage>3864</fpage><lpage>3874</lpage><pub-id pub-id-type="pmid">16597741</pub-id></citation></ref><ref id="pone.0000827-Liedtke4"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liedtke</surname><given-names>W</given-names></name><name><surname>Choe</surname><given-names>Y</given-names></name><name><surname>Marti-Renom</surname><given-names>MA</given-names></name><name><surname>Bell</surname><given-names>AM</given-names></name><name><surname>Denis</surname><given-names>CS</given-names></name><etal/></person-group><year>2000</year><article-title>Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor.</article-title><source>Cell</source><volume>103</volume><fpage>525</fpage><lpage>535</lpage><pub-id pub-id-type="pmid">11081638</pub-id></citation></ref><ref id="pone.0000827-Gao1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>O'Neil</surname><given-names>RG</given-names></name></person-group><year>2003</year><article-title>Temperature-modulated diversity of TRPV4 channel gating: activation by physical stresses and phorbol ester derivatives through protein kinase C-dependent and -independent pathways.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>27129</fpage><lpage>27137</lpage><pub-id pub-id-type="pmid">12738791</pub-id></citation></ref><ref id="pone.0000827-Gler1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;ler</surname><given-names>AD</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Iida</surname><given-names>T</given-names></name><name><surname>Shimizu</surname><given-names>I</given-names></name><name><surname>Tominaga</surname><given-names>M</given-names></name><etal/></person-group><year>2002</year><article-title>Heat-evoked activation of the ion channel, TRPV4.</article-title><source>J Neurosci</source><volume>22</volume><fpage>6408</fpage><lpage>6414</lpage><pub-id pub-id-type="pmid">12151520</pub-id></citation></ref><ref id="pone.0000827-Watanabe3"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Vriens</surname><given-names>J</given-names></name><name><surname>Suh</surname><given-names>SH</given-names></name><name><surname>Benham</surname><given-names>CD</given-names></name><name><surname>Droogmans</surname><given-names>G</given-names></name><etal/></person-group><year>2002</year><article-title>Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>47044</fpage><lpage>47051</lpage><pub-id pub-id-type="pmid">12354759</pub-id></citation></ref><ref id="pone.0000827-Suzuki1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Mizuno</surname><given-names>A</given-names></name><name><surname>Kodaira</surname><given-names>K</given-names></name><name><surname>Imai</surname><given-names>M</given-names></name></person-group><year>2003</year><article-title>Impaired pressure sensation in mice lacking TRPV4.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>22664</fpage><lpage>22668</lpage><pub-id pub-id-type="pmid">12692122</pub-id></citation></ref><ref id="pone.0000827-Liedtke5"><label>31</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Liedtke</surname><given-names>WB</given-names></name></person-group><year>2007</year><article-title>TRPV Channel&#x0015b; Function in Osmo- and Mechanotransduction;</article-title><person-group person-group-type="editor"><name><surname>Liedtke</surname><given-names>WB</given-names></name><name><surname>Heller</surname><given-names>S</given-names></name></person-group><publisher-loc>Boca Raton</publisher-loc><publisher-name>CRC Press</publisher-name><fpage>303</fpage><lpage>318</lpage></citation></ref><ref id="pone.0000827-Todaka1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Todaka</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>J</given-names></name><name><surname>Satoh</surname><given-names>J</given-names></name><name><surname>Mizuno</surname><given-names>A</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name></person-group><year>2004</year><article-title>Warm temperature-sensitive transient receptor potential vanilloid 4 (TRPV4) plays an essential role in thermal hyperalgesia.</article-title><source>J Biol Chem</source><volume>279</volume><fpage>35133</fpage><lpage>35138</lpage><pub-id pub-id-type="pmid">15187078</pub-id></citation></ref><ref id="pone.0000827-AlessandriHaber2"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alessandri-Haber</surname><given-names>N</given-names></name><name><surname>Joseph</surname><given-names>E</given-names></name><name><surname>Dina</surname><given-names>OA</given-names></name><name><surname>Liedtke</surname><given-names>W</given-names></name><name><surname>Levine</surname><given-names>JD</given-names></name></person-group><year>2005</year><article-title>TRPV4 mediates pain-related behavior induced by mild hypertonic stimuli in the presence of inflammatory mediator.</article-title><source>Pain</source><volume>118</volume><fpage>70</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">16213085</pub-id></citation></ref><ref id="pone.0000827-Grant1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grant</surname><given-names>AD</given-names></name><name><surname>Cottrell</surname><given-names>GS</given-names></name><name><surname>Amadesi</surname><given-names>S</given-names></name><name><surname>Trevisani</surname><given-names>M</given-names></name><name><surname>Nicoletti</surname><given-names>P</given-names></name><etal/></person-group><year>2007</year><article-title>Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice.</article-title><source>J Physiol</source><volume>578</volume><fpage>715</fpage><lpage>733</lpage><pub-id pub-id-type="pmid">17124270</pub-id></citation></ref><ref id="pone.0000827-Alvarez1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>DF</given-names></name><name><surname>King</surname><given-names>JA</given-names></name><name><surname>Weber</surname><given-names>D</given-names></name><name><surname>Addison</surname><given-names>E</given-names></name><name><surname>Liedtke</surname><given-names>W</given-names></name><etal/></person-group><year>2006</year><article-title>Transient receptor potential vanilloid 4-mediated disruption of the alveolar septal barrier: a novel mechanism of acute lung injury.</article-title><source>Circ Res</source><volume>99</volume><fpage>988</fpage><lpage>995</lpage><pub-id pub-id-type="pmid">17008604</pub-id></citation></ref><ref id="pone.0000827-Taniguchi1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>J</given-names></name><name><surname>Tsuruoka</surname><given-names>S</given-names></name><name><surname>Mizuno</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>J</given-names></name><name><surname>Fujimura</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>TRPV4 as a flow sensor in flow-dependent K<sup>&#x0002b;</sup> secretion from the cortical collecting duct.</article-title><source>Am J Physiol Renal Physiol</source><volume>292</volume><fpage>F667</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">16954339</pub-id></citation></ref><ref id="pone.0000827-Reiter1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reiter</surname><given-names>B</given-names></name><name><surname>Kraft</surname><given-names>R</given-names></name><name><surname>G&#x000fc;nzel</surname><given-names>D</given-names></name><name><surname>Zeissig</surname><given-names>S</given-names></name><name><surname>Schulzke</surname><given-names>JD</given-names></name><etal/></person-group><year>2006</year><article-title>TRPV4-mediated regulation of epithelial permeability.</article-title><source>FASEB J</source><volume>20</volume><fpage>1802</fpage><lpage>1812</lpage><pub-id pub-id-type="pmid">16940152</pub-id></citation></ref><ref id="pone.0000827-Khler3"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>K&#x000f6;hler</surname><given-names>R</given-names></name><name><surname>Brakemeier</surname><given-names>S</given-names></name><name><surname>K&#x000fc;hn</surname><given-names>M</given-names></name><name><surname>Behrens</surname><given-names>C</given-names></name><name><surname>Real</surname><given-names>R</given-names></name><etal/></person-group><year>2001</year><article-title>Impaired hyperpolarization in regenerated endothelium after balloon catheter injury.</article-title><source>Circ Res</source><volume>89</volume><fpage>174</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">11463725</pub-id></citation></ref><ref id="pone.0000827-Patel1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>AJ</given-names></name><name><surname>Honore</surname><given-names>E</given-names></name><name><surname>Maingret</surname><given-names>F</given-names></name><name><surname>Lesage</surname><given-names>F</given-names></name><name><surname>Fink</surname><given-names>M</given-names></name><etal/></person-group><year>1998</year><article-title>A mammalian two pore domain mechano-gated S-like K<sup>&#x0002b;</sup> channel.</article-title><source>EMBO J</source><volume>17</volume><fpage>4283</fpage><lpage>4290</lpage><pub-id pub-id-type="pmid">9687497</pub-id></citation></ref><ref id="pone.0000827-Garry1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garry</surname><given-names>A</given-names></name><name><surname>Fromy</surname><given-names>B</given-names></name><name><surname>Blondeau</surname><given-names>N</given-names></name><name><surname>Henrion</surname><given-names>D</given-names></name><name><surname>Brau</surname><given-names>F</given-names></name><etal/></person-group><year>2007</year><article-title>Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link.</article-title><source>EMBO Rep</source><volume>8</volume><fpage>354</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">17347672</pub-id></citation></ref><ref id="pone.0000827-Si1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Si</surname><given-names>H</given-names></name><name><surname>Heyken</surname><given-names>WT</given-names></name><name><surname>Wolfle</surname><given-names>SE</given-names></name><name><surname>Tysiac</surname><given-names>M</given-names></name><name><surname>Schubert</surname><given-names>R</given-names></name><etal/></person-group><year>2006</year><article-title>Impaired endothelium-derived hyperpolarizing factor-mediated dilations and increased blood pressure in mice deficient of the intermediate-conductance Ca<sup>2&#x0002b;</sup>-activated K<sup>&#x0002b;</sup> channel.</article-title><source>Circ Res</source><volume>99</volume><fpage>537</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">16873714</pub-id></citation></ref><ref id="pone.0000827-Eichler1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eichler</surname><given-names>I</given-names></name><name><surname>Wibawa</surname><given-names>J</given-names></name><name><surname>Grgic</surname><given-names>I</given-names></name><name><surname>Knorr</surname><given-names>A</given-names></name><name><surname>Brakemeier</surname><given-names>S</given-names></name><etal/></person-group><year>2003</year><article-title>Selective blockade of endothelial Ca<sup>2&#x0002b;</sup>-activated small- and intermediate-conductance K<sup>&#x0002b;</sup>-channels suppresses EDHF-mediated vasodilation.</article-title><source>Br J Pharmacol</source><volume>138</volume><fpage>594</fpage><lpage>601</lpage><pub-id pub-id-type="pmid">12598413</pub-id></citation></ref><ref id="pone.0000827-Rosa1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>JC</given-names></name><name><surname>Galanakis</surname><given-names>D</given-names></name><name><surname>Ganellin</surname><given-names>CR</given-names></name><name><surname>Dunn</surname><given-names>PM</given-names></name><name><surname>Jenkinson</surname><given-names>DH</given-names></name></person-group><year>1998</year><article-title>Bis-quinolinium cyclophanes: 6,10-diaza-3(1,3),8(1,4)-dibenzena-1,5(1,4)- diquinolinacyclodecaphane (UCL 1684), the first nanomolar, non-peptidic blocker of the apamin-sensitive Ca<sup>2&#x0002b;</sup>-activated K<sup>&#x0002b;</sup> channel.</article-title><source>J Med Chem</source><volume>41</volume><fpage>2</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">9438015</pub-id></citation></ref><ref id="pone.0000827-Wulff1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wulff</surname><given-names>H</given-names></name><name><surname>Miller</surname><given-names>MJ</given-names></name><name><surname>Hansel</surname><given-names>W</given-names></name><name><surname>Grissmer</surname><given-names>S</given-names></name><name><surname>Cahalan</surname><given-names>MD</given-names></name><etal/></person-group><year>2000</year><article-title>Design of a potent and selective inhibitor of the intermediate-conductance Ca<sup>2&#x0002b;</sup>-activated K<sup>&#x0002b;</sup> channel, IKCa1: a potential immunosuppressant.</article-title><source>Proc Natl Acad Sci U S A</source><volume>97</volume><fpage>8151</fpage><lpage>8156</lpage><pub-id pub-id-type="pmid">10884437</pub-id></citation></ref><ref id="pone.0000827-Mutai1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mutai</surname><given-names>H</given-names></name><name><surname>Heller</surname><given-names>S</given-names></name></person-group><year>2003</year><article-title>Vertebrate and invertebrate TRPV-like mechanoreceptors.</article-title><source>Cell Calcium</source><volume>33</volume><fpage>471</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">12765692</pub-id></citation></ref><ref id="pone.0000827-AlessandriHaber3"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alessandri-Haber</surname><given-names>N</given-names></name><name><surname>Yeh</surname><given-names>JJ</given-names></name><name><surname>Boyd</surname><given-names>AE</given-names></name><name><surname>Parada</surname><given-names>CA</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group><year>2003</year><article-title>Hypotonicity induces TRPV4-mediated nociception in rat.</article-title><source>Neuron</source><volume>39</volume><fpage>497</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">12895423</pub-id></citation></ref><ref id="pone.0000827-Falcone1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falcone</surname><given-names>JC</given-names></name><name><surname>Kuo</surname><given-names>L</given-names></name><name><surname>Meininger</surname><given-names>GA</given-names></name></person-group><year>1993</year><article-title>Endothelial cell calcium increases during flow-induced dilation in isolated arterioles.</article-title><source>Am J Physiol</source><volume>264</volume><fpage>H653</fpage><lpage>659</lpage><pub-id pub-id-type="pmid">8447477</pub-id></citation></ref><ref id="pone.0000827-Muller1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>MJ</given-names></name><name><surname>Kuo</surname><given-names>L</given-names></name><name><surname>Chilian</surname><given-names>WM</given-names></name></person-group><year>1999</year><article-title>Changes in coronary endothelial cell Ca<sup>2&#x0002b;</sup> concentration during shear stress- and agonist-induced vasodilation.</article-title><source>Am J Physiol</source><volume>276</volume><fpage>H1706</fpage><lpage>1714</lpage><pub-id pub-id-type="pmid">10330257</pub-id></citation></ref><ref id="pone.0000827-Fleming1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fleming</surname><given-names>I</given-names></name><name><surname>Bauersachs</surname><given-names>J</given-names></name><name><surname>Fisslthaler</surname><given-names>B</given-names></name><name><surname>Busse</surname><given-names>R</given-names></name></person-group><year>1998</year><article-title>Ca<sup>2&#x0002b;</sup>-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress.</article-title><source>Circ Res</source><volume>82</volume><fpage>686</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">9546377</pub-id></citation></ref><ref id="pone.0000827-Gudermann1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gudermann</surname><given-names>T</given-names></name><name><surname>Flockerzi</surname><given-names>V</given-names></name></person-group><year>2005</year><article-title>TRP channels as new pharmacological targets.</article-title><source>Naunyn Schmiedebergs Arch Pharmacol</source><volume>371</volume><fpage>241</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">15756597</pub-id></citation></ref><ref id="pone.0000827-Wissenbach1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wissenbach</surname><given-names>U</given-names></name><name><surname>Niemeyer</surname><given-names>BA</given-names></name><name><surname>Flockerzi</surname><given-names>V</given-names></name></person-group><year>2004</year><article-title>TRP channels as potential drug targets.</article-title><source>Biol Cell</source><volume>96</volume><fpage>47</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">15093127</pub-id></citation></ref><ref id="pone.0000827-Maier1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maier</surname><given-names>T</given-names></name><name><surname>Grgic</surname><given-names>I</given-names></name><name><surname>Busch</surname><given-names>C</given-names></name><name><surname>Hoyer</surname><given-names>J</given-names></name><name><surname>K&#x000f6;hler</surname><given-names>R</given-names></name></person-group><year>2005</year><article-title>&#x0005b;Endothelial ion channels&#x02013;novel targets for antihypertensive therapy&#x0005d;.</article-title><source>Dtsch Med Wochenschr</source><volume>130</volume><fpage>2637</fpage><lpage>2639</lpage><pub-id pub-id-type="pmid">16281159</pub-id></citation></ref><ref id="pone.0000827-Fukunaga1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukunaga</surname><given-names>R</given-names></name><name><surname>Hirano</surname><given-names>K</given-names></name><name><surname>Hirano</surname><given-names>M</given-names></name><name><surname>Niiro</surname><given-names>N</given-names></name><name><surname>Nishimura</surname><given-names>J</given-names></name><etal/></person-group><year>2006</year><article-title>Upregulation of proteinase-activated receptors and hypercontractile responses precede development of arterial lesions after balloon injury.</article-title><source>Am J Physiol Heart Circ Physiol</source><volume>291</volume><fpage>H2388</fpage><lpage>2395</lpage><pub-id pub-id-type="pmid">16844909</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>RK, JH and CH were supported by the Deutsche Forschungsgemeinschaft (P A11 of the SFB593 (JH, RK) and P4 of the FOR 667; CH); WL was supported by a K08 Career Development Award of the National Institute of Mental Health (Bethesda, MD, USA), by funding from the Whitehall Foundation (Palm Springs, FL, USA), the Klingenstein Fund (New York, NY, USA) and by the Duke University (Durham, NC, USA). All funders had no influence in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.</p></fn></fn-group></back></article> 